IL6 and cancer: More importantly, studies focusing on reversing the adverse influence of endogenous GC on immunity and immunotherapy, such as controlling cancer-related depress and chronic stress with agents, combined IL-6 blockade, and interrupting the GR signaling with targeted molecules, are urgently expected.